PRESS RELEASE published on 09/09/2025 at 07:00, 2 months 26 days ago Sandoz reaches agreement with Regeneron, resolving all patent litigation related to its US aflibercept biosimilar Sandoz reaches agreement with Regeneron on patent litigation related to US aflibercept biosimilar, enabling launch of Enzeevu™ by end of 2026. Agreement strengthens Sandoz biosimilar portfolio and expands US market growth strategy Biosimilar Patent Litigation Sandoz Regeneron Enzeevu
BRIEF published on 08/28/2025 at 07:05, 3 months 8 days ago Sandoz Expands Rivaroxaban Access in Germany Patent Germany Sandoz Rivaroxaban Antithrombotic
BRIEF published on 08/28/2025 at 07:05, 3 months 8 days ago Sandoz élargit l'accès au rivaroxaban en Allemagne Allemagne Brevet Sandoz Rivaroxaban Antithrombotique
PRESS RELEASE published on 08/28/2025 at 07:00, 3 months 8 days ago Sandoz launches rivaroxaban in Germany, expanding access to high-quality antithrombotic treatment options Sandoz launches rivaroxaban in Germany, expanding access to high-quality antithrombotic treatment options Germany Sandoz Antithrombotic Treatment Rivaroxaban Generic Medicine
Published on 12/05/2025 at 02:35, 4 hours 50 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 25 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 20 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 25 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 24 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 3 hours 54 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 34 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 59 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 10 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:14, 13 hours 10 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 13 hours 25 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 13 hours 25 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 40 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 13 hours 40 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
